The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The global Oncolytic Virus market was valued at US$ 16 million in 2020 and is expected to reach US$ 26 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
This report focuses on Oncolytic Virus volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Oncolytic Virus Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amgen
Shanghai Sunway Biotech
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The global Oncolytic Virus market was valued at US$ 16 million in 2020 and is expected to reach US$ 26 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
This report focuses on Oncolytic Virus volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Oncolytic Virus Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amgen
Shanghai Sunway Biotech
Index1 Oncolytic Virus Market Overview
1.1 Product Overview and Scope of Oncolytic Virus
1.2 Oncolytic Virus Segment by Type
1.2.1 Global Oncolytic Virus Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Oncolytic Virus Segment by Application
1.3.1 Global Oncolytic Virus Sales Comparison by Application: (2021-2027)
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Global Oncolytic Virus Market Size Estimates and Forecasts
1.4.1 Global Oncolytic Virus Revenue 2016-2027
1.4.2 Global Oncolytic Virus Sales 2016-2027
1.4.3 Oncolytic Virus Market Size by Region: 2016 Versus 2021 Versus 2027
2 Oncolytic Virus Market Competition by Manufacturers
2.1 Global Oncolytic Virus Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oncolytic Virus Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oncolytic Virus Manufacturing Sites, Area Served, Product Type
2.5 Oncolytic Virus Market Competitive Situation and Trends
2.5.1 Oncolytic Virus Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oncolytic Virus Players Market Share by Revenue
2.5.3 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncolytic Virus Retrospective Market Scenario by Region
3.1 Global Oncolytic Virus Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Oncolytic Virus Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Oncolytic Virus Market Facts & Figures by Country
3.3.1 North America Oncolytic Virus Sales by Country
3.3.2 North America Oncolytic Virus Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oncolytic Virus Market Facts & Figures by Country
3.4.1 Europe Oncolytic Virus Sales by Country
3.4.2 Europe Oncolytic Virus Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncolytic Virus Market Facts & Figures by Region
3.5.1 Asia Pacific Oncolytic Virus Sales by Region
3.5.2 Asia Pacific Oncolytic Virus Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oncolytic Virus Market Facts & Figures by Country
3.6.1 Latin America Oncolytic Virus Sales by Country
3.6.2 Latin America Oncolytic Virus Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncolytic Virus Sales by Country
3.7.2 Middle East and Africa Oncolytic Virus Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oncolytic Virus Historic Market Analysis by Type
4.1 Global Oncolytic Virus Sales Market Share by Type (2016-2021)
4.2 Global Oncolytic Virus Revenue Market Share by Type (2016-2021)
4.3 Global Oncolytic Virus Price by Type (2016-2021)
5 Global Oncolytic Virus Historic Market Analysis by Application
5.1 Global Oncolytic Virus Sales Market Share by Application (2016-2021)
5.2 Global Oncolytic Virus Revenue Market Share by Application (2016-2021)
5.3 Global Oncolytic Virus Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amgen Oncolytic Virus Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Shanghai Sunway Biotech
6.2.1 Shanghai Sunway Biotech Corporation Information
6.2.2 Shanghai Sunway Biotech Description and Business Overview
6.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
6.2.5 Shanghai Sunway Biotech Recent Developments/Updates
7 Oncolytic Virus Manufacturing Cost Analysis
7.1 Oncolytic Virus Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncolytic Virus
7.4 Oncolytic Virus Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncolytic Virus Distributors List
8.3 Oncolytic Virus Customers
9 Oncolytic Virus Market Dynamics
9.1 Oncolytic Virus Industry Trends
9.2 Oncolytic Virus Growth Drivers
9.3 Oncolytic Virus Market Challenges
9.4 Oncolytic Virus Market Restraints
10 Global Market Forecast
10.1 Oncolytic Virus Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oncolytic Virus by Type (2022-2027)
10.2 Oncolytic Virus Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncolytic Virus by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oncolytic Virus by Application (2022-2027)
10.3 Oncolytic Virus Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncolytic Virus by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oncolytic Virus by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oncolytic Virus Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oncolytic Virus Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Oncolytic Virus Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oncolytic Virus Covered in This Study
Table 5. Global Oncolytic Virus Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Oncolytic Virus Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Oncolytic Virus Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oncolytic Virus Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oncolytic Virus Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oncolytic Virus Manufacturing Sites and Area Served
Table 11. Manufacturers Oncolytic Virus Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oncolytic Virus Sales by Region (2016-2021) & (K Units)
Table 16. Global Oncolytic Virus Sales Market Share by Region (2016-2021)
Table 17. Global Oncolytic Virus Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 19. North America Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 20. North America Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 22. Europe Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 23. Europe Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 24. Europe Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oncolytic Virus Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Oncolytic Virus Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oncolytic Virus Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oncolytic Virus Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 32. Latin America Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 38. Global Oncolytic Virus Sales (K Units) by Type (2016-2021)
Table 39. Global Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 40. Global Oncolytic Virus Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oncolytic Virus Revenue Share by Type (2016-2021)
Table 42. Global Oncolytic Virus Price (US$/Unit) by Type (2016-2021)
Table 43. Global Oncolytic Virus Sales (K Units) by Application (2016-2021)
Table 44. Global Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 45. Global Oncolytic Virus Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oncolytic Virus Revenue Share by Application (2016-2021)
Table 47. Global Oncolytic Virus Price (US$/Unit) by Application (2016-2021)
Table 48. Amgen Corporation Information
Table 49. Amgen Description and Business Overview
Table 50. Amgen Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Amgen Oncolytic Virus Product
Table 52. Amgen Recent Developments/Updates
Table 53. Shanghai Sunway Biotech Corporation Information
Table 54. Shanghai Sunway Biotech Description and Business Overview
Table 55. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Shanghai Sunway Biotech Oncolytic Virus Product
Table 57. Shanghai Sunway Biotech Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Oncolytic Virus Distributors List
Table 61. Oncolytic Virus Customers List
Table 62. Oncolytic Virus Market Trends
Table 63. Oncolytic Virus Growth Drivers
Table 64. Oncolytic Virus Market Challenges
Table 65. Oncolytic Virus Market Restraints
Table 66. Global Oncolytic Virus Sales Forecast by Type (2022-2027) & (K Units)
Table 67. Global Oncolytic Virus Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Oncolytic Virus Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Oncolytic Virus Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Oncolytic Virus Sales Forecast by Application (2022-2027) & (K Units)
Table 71. Global Oncolytic Virus Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Oncolytic Virus Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Oncolytic Virus Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Oncolytic Virus Sales Forecast by Region (2022-2027) & (K Units)
Table 75. Global Oncolytic Virus Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Oncolytic Virus Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Oncolytic Virus Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncolytic Virus
Figure 2. Global Oncolytic Virus Market Share by Type in 2020 & 2027
Figure 3. Imlygic Product Picture
Figure 4. Oncorine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oncolytic Virus Market Share by Application in 2020 & 2027
Figure 7. Melanoma
Figure 8. Other Cancers
Figure 9. Global Oncolytic Virus Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Oncolytic Virus Market Size 2016-2027 (US$ Million)
Figure 11. Global Oncolytic Virus Sales 2016-2027 (K Units)
Figure 12. Global Oncolytic Virus Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Oncolytic Virus Sales Share by Manufacturers in 2020
Figure 14. Global Oncolytic Virus Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Oncolytic Virus Players: Market Share by Revenue in 2020
Figure 16. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Oncolytic Virus Sales Market Share by Region (2016-2021)
Figure 18. Global Oncolytic Virus Sales Market Share by Region in 2020
Figure 19. Global Oncolytic Virus Revenue Market Share by Region (2016-2021)
Figure 20. Global Oncolytic Virus Revenue Market Share by Region in 2020
Figure 21. U.S. Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Oncolytic Virus by Type (2016-2021)
Figure 46. Sales Market Share of Oncolytic Virus by Application (2016-2021)
Figure 47. Sales Market Share of Oncolytic Virus by Application in 2020
Figure 48. Revenue Share of Oncolytic Virus by Application (2016-2021)
Figure 49. Revenue Share of Oncolytic Virus by Application in 2020
Figure 50. Manufacturing Cost Structure of Oncolytic Virus
Figure 51. Manufacturing Process Analysis of Oncolytic Virus
Figure 52. Oncolytic Virus Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
